Genmab A/S Sponsored ADR (GMAB) vs Vertex Pharmaceuticals Incorporated (VRTX)

• Genmab A/S Sponsored ADR GMAB 53.48 ▲ +1.40%
• Vertex Pharmaceuticals Incorporated VRTX 546.95 ▲ +0.82%

Genmab A/S Sponsored ADR and Vertex Pharmaceuticals Incorporated are both Biotechnology companies. Vertex Pharmaceuticals Incorporated is the larger, with a market value of $137.5B against $31.5B — 4.4× the size. Vertex Pharmaceuticals Incorporated trades at the lower P/E: 34.6× against 41.7×. Genmab A/S Sponsored ADR grew revenue faster over the last twelve months: 22.3% against 10.5%. Vertex Pharmaceuticals Incorporated has the higher net margin (30.7% vs 19.1%) and the higher return on invested capital (14.9% vs 6.99%). Across the 21 metrics below, Vertex Pharmaceuticals Incorporated leads on 14 and Genmab A/S Sponsored ADR on 7.